Pelican Therapeutics, Inc.

Biotechnology company · Austin, Texas, United States

Pelican Therapeutics, Inc. is a biotechnology company headquartered in Austin, Texas, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $224,713 in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $250,000 sold in a notice filed in 2015.

www.pelicantherapeutics.comProfile compiled from public records. Is this your company? Request a correction or update

Pelican Therapeutics at a glance

Typebiotechnology company
HeadquartersAustin, Texas, United States
Employees (self-reported, 2020)25
SEC CIK1610154

What does Pelican Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $224,713 in total (2020). NIH funding came from the National Institute of Allergy and Infectious Diseases.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $250,000 sold (2015).

Frequently asked questions about Pelican Therapeutics

Where is Pelican Therapeutics headquartered?

Pelican Therapeutics, Inc. is headquartered in Austin, Texas, United States.

What does Pelican Therapeutics do?

Pelican Therapeutics, Inc. is a biotechnology company.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences